We finally demonstrated that FLOT1 might enhance radioresistance through facilitating EMT process, suppressing radiation-induced DNA damage, and reprogramming the tumor immune microenvironment via STING signaling pathways in NSCLC. Here, FLOT1 is linked to non-small cell lung carcinoma.